Replies to post #5297 on BioPharm Asia, Inc (fka BFAR)

[fcpgalltheway]

Below is the headline the way it appeared ion the US.

BioPharm Asia Acquires Specialty Hospital in Fujian

NEW YORK, NY and TONGHUA, CHINA--(Marketwire -01/26/12)- BioPharm Asia, Inc. (Pinksheets: BFAR.PK - News) (the "Company")

The red colored words appeared only in the USA.

Now take a look at the headline in China in Xiamen. No Marketwire is ever mentioned; the words say TO ACQUIRE; IT SPECIFIES THE HOSPITAL BY NAME...Xiamen Tongji Hospital.

BioPharm Asia to acquire Xiamen Tongji Hospital
BioPharm Asia, Inc. (pinksheets:BFAR) (the "Company")


This tell me that the company modified the news release especially for the Xiamen website. It's either to be truthful or to continue lying in their own way.

My only puzzlement is to understand if this company is the one that has all the big sales by the millions or the scam company that fails to file reports with the SEC because it has something to hide. Remember a company that has sales of over $100 million can afford to pay CPAs to file the reports with the SEC in proper format. And also, why would a company with as big EPS and sales be languishing or would want to stay at 5 cents a share when by publishing SEC filed earnings it would have its stock go up to one dollar or more??? ANY COMMENTS FROM OTHER POSTERS.